Pharmaceutical Technology | Drug Development News & Views …
WEBPharmaceutical news and in-depth feature articles on the new drug discoveries, healthcare research and development, big pharma trends and company deals.
mRNA licensing agreements double with million-dollar deals
WEB1 day ago · mRNA-based pharmaceuticals’ licensing agreement deal values doubled since 2023 to reach $3.8bn, with large pharma companies like GSK and Bristol Myers Squibb investing in the development of mRNA therapeutics and recognising their potential to address unmet medical needs across a range of diseases.. In July 2024, GSK and Curevac restructured their 2020 collaboration into a new licensing ...
Artificial Intelligence in Pharma: Innovations, Patents, and Trends
WEBAug 20, 2024 · Pharmaceutical companies are increasingly harnessing artificial intelligence (AI) to advance research and development, resulting in groundbreaking healthcare solutions. Recent innovations include AI-driven cancer treatment target identification, optimized drug combinations, and automated systems …
Pharma breakthroughs: 10 novel drug approvals that made …
WEBDec 20, 2023 · Around 10 million people worldwide will die from cancer every year and approximately 685,000 of those deaths will be due to breast cancer. Orerdu (elacestrant) is a selective oestrogen receptor degrader (SERD) marketed by Stemline Therapeutics – a subsidiary of Menarini in the U.S.
CD7 CAR-T cell therapy shows promise for leukaemia
WEB1 day ago · The National University of Singapore’s Yong Loo Lin School of Medicine (NUS Medicine) and the NUHS developed the cell therapy, which targets CD7 on leukaemia cells. This fratricide-resistant therapy was administered to 17 patients at the NUH in Singapore and at the Ospedale Pediatrico Bambino Gesù in …
Pharmaceutical Technology’s most-read stories of 2023
WEBDec 19, 2023 · As the year comes to a close, we at Pharmaceutical Technology take stock at some of the biggest headlines of the year. One of the most popular stories on the site was a forward-looking feature that outlined the biggest expected catalysts involving CRISPR gene therapies and posited 2023 as the milestone year for this approach. The interest in this cutting edge technology was unsurprising given ...
Pharma developments in 2022: what you need to know
WEBJan 5, 2022 · By GlobalData. The Covid-19 pandemic significantly altered the clinical trials landscape, and a Clinical Trials Arena analysis by Andrew and Kezia Parkins shows the frequency of decentralised clinical trials will reach new heights in 2022, with a 28% jump from last year. Looking at the bigger picture, Andrew reports that middle-income countries ...
How technology could transform drug research in 2022
WEBDec 14, 2021 · Pharmaceutical Technology takes a look at some of the tech innovations set to impact drug discovery and development in 2022. When we think of new technologies in medicine, we tend to conjure images of futuristic AI computers, 3D-printed organs, and robot surgeons. The ambitious and lesser-explored methods currently being applied in …
The future of cell and gene therapy manufacturing
WEBDec 1, 2023 · The global pharmaceutical industry finds itself at a compelling intersection. The next five years will signify a critical period with the adoption of a combination of technological advancements, strategic partnerships, and major shifts in drug discovery, manufacturing, and distribution.. While the scope of cell and gene therapies continues to grow, experts gathered at the recent CPHI Europe ...
Mapping the RNA therapeutics R&D landscape in 2022
WEBDec 17, 2021 · A look at the planned studies in 2022, as per GlobalData, however indicate a broader landscape of RNA-focused vaccines and therapeutics that look at oncology, ophthalmology, and infectious diseases. Trials with more than two dozen novel RNA therapeutics or vaccines are expected to start in 2022, as per a GlobalData analysis.